Metabolic Diseases of Muscle

Lumizyme Now Commercially Available for Pompe

 Monique Griffin of Orlando, Fla., was one of the first in the nation to receive the commercially available treatment Lumizyme for acid maltase deficiency (AMD, or Pompe disease).

New Mattie Book

 MDA National Vice President Jeni Stepanek will be a guest on the November 2 broadcast of ABC's "Good Morning America" to promote the release of Messenger: The Legacy of Mattie J. T. Stepanek and Heartsongs, an inside look at the life of her famous son, who served as MDA’s National Goodwill Ambassador from 2002-2004.

MDA Scientists Win Federal Stimulus Grants for Neuromuscular Disease Research

At least 15 Muscular Dystrophy Association research grantees, past and present, have won funding from the National Institutes of Health through the American Recovery and Revitalization Act (ARRA) to accelerate the search for treatments and cures for neuromuscular diseases.

Mito Disease Research: New Prevention Strategy

Scentists at Oregon Health and Science University in Portland have developed an assisted-reproduction technique that has the potential to allow mothers with mitochondrial myopathies and other mitochondrial diseases to virtually eliminate the risk of passing on the disease to their children.

FDA OKs Lifesaving Treatment for Pompe Disease

TUCSON, Ariz., April 28, 2006 — The Food and Drug Administration today announced approval of Myozyme, a new treatment for patients with Pompe disease, a rare genetic disorder also known as acid maltase enzyme deficiency.